On March 17, Aimed Alliance sent a letter to the Michigan legislature urging the Senate Committee on Finance, Insurance, and Consumer Protection to carefully assess the potential impacts of S.B. 3, which would establish a prescription drug affordability board. The letter urged the committee to consider alternative legislation that could more effectively reduce prescription drug costs for consumers, such as implementing a copay accumulator ban or establishing step therapy safeguards. Additionally, Aimed Alliance urged the committee to prioritize patients by appointing a consumer or patient advocate to the Board and ensuring continuous consumer engagement, if it moved forward with the PDAB legislation. Read the letter here.
Last Updated on March 19, 2025 by Aimed Alliance
